PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 57 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $56 | -42.3% | 14,601 | -28.4% | 0.00% | – |
| Q1 2024 | $97 | -26.0% | 20,387 | -33.2% | 0.00% | – |
| Q4 2023 | $131 | +211.9% | 30,526 | +129.2% | 0.00% | – |
| Q3 2023 | $42 | +55.6% | 13,316 | +120.0% | 0.00% | – |
| Q2 2023 | $27 | -54.2% | 6,052 | -41.4% | 0.00% | – |
| Q1 2023 | $59 | -89.3% | 10,322 | -88.6% | 0.00% | – |
| Q4 2022 | $549 | -98.4% | 90,824 | +1657.4% | 0.00% | – |
| Q3 2022 | $34,000 | +61.9% | 5,168 | +27.3% | 0.00% | – |
| Q2 2022 | $21,000 | -47.5% | 4,060 | -30.9% | 0.00% | – |
| Q1 2022 | $40,000 | – | 5,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,909,256 | $41,564,265 | 0.82% |
| Boxer Capital, LLC | 2,568,287 | $9,785,173 | 0.52% |
| Baker Brothers Advisors | 10,123,824 | $38,571,769 | 0.49% |
| Sio Capital Management, LLC | 320,394 | $1,220,701 | 0.33% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,133,000 | $15,746,730 | 0.26% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 123,600 | $470,916 | 0.01% |
| EXCHANGE TRADED CONCEPTS, LLC | 48,727 | $185,650 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 18,839 | $71,777 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11,074 | $42,192 | 0.00% |
| KENNEDY CAPITAL MANAGEMENT LLC | 35,283 | $134,428 | 0.00% |